The Chronic Obstructive Pulmonary Disease (COPD) treatment market encompasses a diverse portfolio of pharmacological products—including bronchodilators, corticosteroids, combination inhalers, phosphodiesterase inhibitors, and biologics—designed to relieve symptoms, improve lung function, and reduce exacerbations. Inhaler devices such as pressurized metered‐dose inhalers (pMDIs), dry‐p... https://www.patreon.com/posts/chronic-disease-131650577?utm_medium=clipboard_copy&utm_source=copyLink&utm_campaign=postshare_creator&utm_content=join_link